Hosted by Chris O'Brien · 🇺🇸 US · EN · 35 episodes
Established thought leaders with verified media credentials.
Welcome to Few & Far Between! Melissa Alesse, President of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders.
Chris O'Brien hosts Few & Far Between: How Biotech Gets Built, a science show with 35 episodes published.
Today on the Biorasi Few & Far Between podcast: What's trending in the CRO market? Find out as host Melissa Alesse welcomes Joel White, owner of Marketcap Consulting and 20+ year veteran of the CRO industry. We'll uncove
Today on the Biorasi Few & Far Between podcast: Join new host Melissa Alesse and former host Chris O'Brien - CEO at Rancho BioSciences and Biorasi Board member - as they explore the origins and evolution of our podcast a
Today on the Biorasi podcast, we look back on three years of AI innovation in healthcare and clinical trials - breaking new boundaries and a creating a new reality across all industries. Host Chris O'Brien welcomes back
How do today’s CEOs and founders find the balance between planning and entrepreneurship? Check out the latest episode of the Biorasi Few & Far Between podcast - How Biotech Gets Built. Host Chris O'Brien welcomes Sinan G
Let's kick off 2026 with the first Biorasi podcast episode of the year! How do you get "Biotech Vision" to see the complete picture of your place in the industry? Find out in the latest episode of the Few & Far Between p
Are clinical trial protocols a true art form? Find out in a new episode of the Biorasi Few & Far Between podcast. Host Chris O'Brien welcomes guest Mark Ableson, founder of Ora Clinical and CRO pioneer. We'll be discussi
With biotech, is it the destination, the journey, or both? Find out in a new episode of the Biorasi Few & Far Between podcast. Host Chris O'Brien welcomes guest Amit Etkin, Founder and CEO of Alto Neuroscience and Profes
Will GLP-1's one day replace our morning coffee? Find out in a special video episode of the Few & Far Between podcast! Host Chris O'Brien welcomes friend of the show, Professor Justin Stebbing. In this new segment, we'll
What if the future of biotech is actually late-stage execution? Welcome to our first video episode of the Biorasi Few & Far Between podcast with your host, Chris O’Brien. Today, we welcome guest Bruce Leuchter, MD, Presi
When is the right time for a biotech to bring in a Chief Marketing Officer/CMO? Find out in our latest episode of the Biorasi Few & Far Between podcast! Host Chris O'Brien welcomes Ken Suzuki, Chief Marketing Officer at
Why is a feather-light touch important in fighting infections? Find out in our latest episode of the Biorasi Few & Far Between podcast! Host Chris O'Brien welcomes Woody Bryan, President and CEO of Revolo Biotherapeutics
Can AI see and talk to human cells? Find out in today's episode of the Biorasi Few & Far Between podcast. Host Chris O'Brien welcomes Yochi Slonim, Co-Founder and CEO at Anima Biotech, to the podcast. Get ready for part
What do software bugs and human cells have in common? Find out in today's episode of the Biorasi Few & Far Between podcast. Host Chris O'Brien welcomes Yochi Slonim, Co-Founder and CEO at Anima Biotech, to the podcast. T
How does a biopharma background prepare you for the biotech playground? Find out in our latest episode of the Biorasi Few & Far Between podcast! Host Chris O'Brien welcomes Jerry McLaughlin, CEO and Board Member at Life
Is the epigenome the "software" of the cell nucleus? Find out in our latest episode of the Biorasi Few & Far Between podcast! Host Chris O'Brien welcomes Jim Brown, President and CEO of DURECT Corporation, for a conversa
How do experienced troubleshooters solve a difficult problem? By asking the right questions first! Welcome back to part two of our conversation with Michael Tolentino, MD, Co-Founder and Head Scientific Consultant at Avi
How much do you know about clinical trials in Latin America? Take a deep dive with us as we explore the benefits and risks of running studies in this region. In our latest episode of the Biorasi Few & Far Between podcast
The challenge? Decoding the human immune system. Get ready to meet the top challenger on today's episode of the Biorasi Few & Far Between podcast. Host Chris O'Brien welcomes Michael Tolentino, MD, Co-Founder and Head Sc
How do mission, vision, and data analysis fit into today's biotech goals? Host Chris O'Brien welcomes Frank David, Founder and Managing Director of Pharmagellan to the podcast. Tune in as we explore R&D strategy, de-risk
How does a biotech balance great science with IP security to tell their story? Find out on today's episode of the Few & Far Between podcast! Host Chris O'Brien welcomes Joshua Kresh, Emily Michiko Morris, and Mark Schult
Chris O'Brien
Products and Services director · Senator Margaret Chase Smith Library
1 appearance on this show
Chris O'Brien
Director · New York State Sheriffs' Institute
1 appearance on this show
Dr Aoife Brennan
President and CEO · Climb Bio
1 appearance on this show
Justin Stebbing
Professor
1 appearance on this show
Jim Brown
Former Secretary of State · The Sarah Leonard Team at Legacy Properties
1 appearance on this show
Julio G. Martinez-Clark
CEO of bioaccess® and Synapse Global Theranostics, CSO of amavita Heart and Vascular Health® · Synapse Global Theranostics
1 appearance on this show
Mark Schultz
Chair in Intellectual Property and Director of the Intellectual Property and Technology Law Program at the University of Akron School of Law · Goodyear Tire and Rubber Company
1 appearance on this show
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Few & Far Between: How Biotech Gets Built has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their science audience.
Few & Far Between: How Biotech Gets Built is hosted by Chris O'Brien. The show is categorised under science (life) and has published 35 episodes.
Few & Far Between: How Biotech Gets Built has published 35 episodes.
Few & Far Between: How Biotech Gets Built regularly covers science, life, health. It sits in the science category, with a life focus.
Few & Far Between: How Biotech Gets Built is accessible for guests with genuine science expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
Few & Far Between: How Biotech Gets Built hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of Few & Far Between: How Biotech Gets Built average 49 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates Few & Far Between: How Biotech Gets Built's guest bar at 81/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched yesterday.
